2007: Metabolic and Crystal Arthropathies
Search or Browse by Day

Metabolic and Crystal Arthropathies

Saturday, November 10, 2007
1614
Effect of Phosphate on Fibroblast-like Synoviocytes
1615
Contrast Phase Microscopy Highly Improves Detection of Calcium Pyrophosphate Dihydrate (CPPD) Crystals in Synovial Fluid Samples
1616
Detection of Synovial Fluid Calcium Phosphate Crystals: A Route to Improved Diagnosis and Characterisation of Osteoarthritis
1617
Metabolic Syndrome and Cardiovascular Risk in Patients with Diffuse Idiopathic Skeletal Hyperostosis (DISH)
1618
Ultrasound Detects Calcium Pyrophosphate Dehydrate Crystal Deposition in Hyaline Cartilage more Readily than Conventional Radiography and MRI in Pyrophosphate Arthropathy
1619
Sodium-Dependent Phosphate Cotransporter Type 1 (NPT1) Sequence Polymorphisms in Patients with Gout
1620
Uric Acid Directly Promotes T Cell Autoreactivity
1621
Blood Uric Acid (UA) Measurements Using a Handheld Electrochemical UA Meter are Comparable to Those Obtained with Current Analytical Standard
1622
Urate-Lowering Pharmacotherapy with Febuxostat (FEB) or Allopurinol (ALLO) in African-American Subjects with Gout
1623
Expression and Function of Cytokines in Gouty Arthritis
1624
A Modified Delphi Exercise to Determine the Extent of Consensus with OMERACT Outcome Domains for Studies of Acute and Chronic Gout
1625
Gout and the Risk of Type 2 Diabetes
1626
Diagnosis of Gout in the Rheumatology, Hospital-Based Setting Lies Far from that Recommended: Results from the GEMA (Gout Evaluation Of Management) Study
1627
Validation of Gout Clinical Diagnostic Criteria in VA Patients Compared with the Gold Standard of Synovial Fluid Crystal Analysis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>